CURIS INC

Nasdaq: CRIS

Day 58 public/EARLY PUBLIC/IPO Aug 13, 2026/Biological Products, (No Diagnostic Substances)

$0.67

▼ 0.04 (-5.38%)

LIVE

updated 16h ago

Intelligence Core

MONITORING

No new filings in 72 h · watching for the next event

Current missionThesis Test · Day 31–90

Test the initial thesis against the first earnings, guidance and execution.

Focus

EarningsGuidanceExecutionInstitutional changes

CAUTIOUSFORMING THESIS…Intelligence score DERIVED

/ 100

Confidence65%

CURRENT THESIS INTERPRETED

Curis Inc is an early public clinical-stage biological products company trading below one dollar with weak 1-day momentum, reflecting ongoing operational losses typical of its sector despite reported revenue, cash, and positive equity.

Momentum

Price · since IPOLIVE

Yahoo · 65 pts

H $5.15L $0.67Last $0.67

Current ThesisINTERPRETEDLIVE

Why

+Fundamentals show reported revenue, net loss, cash on balance sheet, and positive equity based on SEC XBRL filings
+High institutional engagement with 6 Schedule 13D/13G disclosures on file with the SEC
+Active corporate and insider narrative activity with 8 8-K filings and 14 insider forms

Risks

−Newly public status under 90 days with elevated risk profile inherent to the clinical-stage sector
−Share price trading at $0.6712 with negative 1-day momentum of -5.38% and a momentum score of 39
−Ongoing operational net losses typical for biological products companies

Catalysts

→Future SEC filings including upcoming 10-Q and periodic reports
→Updates regarding clinical-stage pipeline developments disclosed via 8-K filings

Current Thesis

Company Web Research · Official DomainVIEW ONLY

https://curis.com

VIEW-ONLY

Visit

LIVE · SANDBOXED

Resolving official website…

Research EnvironmentLIVE

Research environment · $CRISSEC · market · news

18 evidence items|newest evidence 1d ago

Core activity · newest firstreal events · view-only

0s agoSCOREDERIVEDIntelligence score 73/100 recomputed from 5 rule-based signals.via Deterministic scoreDERIVED

0s agoSTATECore MONITORING · No new filings in 72 h · watching for the next event. Mission: Thesis Test.via Intelligence Core

16h agoOBSERVATIONVERIFIEDLast price $0.67 · -5.38% on the day.via Finnhub quoteVERIFIED

1d agoEVIDENCEWhy Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarketvia Benzinga · tier 3, cross-check 44d agoEVIDENCEVISTA Inhibitor Market Insights Report 2026 | Featuring Profiles of Aurigene Discovery Technologies, Curis, Hummingbird Bioscience, Kineta, PharmAbcinevia Yahoo · tier 3, cross-check 52d agoEVIDENCE12 Health Care Stocks Moving In Tuesday's After-Market Sessionvia Benzinga · tier 3, cross-check Aug 14, 2026EVIDENCEVERIFIEDForm 10-Q filed · 10-Q.via SEC EDGARVERIFIED Aug 13, 2026EVIDENCEVERIFIEDForm 424B4 filed · 424B4.via SEC EDGARVERIFIED Aug 12, 2026EVIDENCEVERIFIEDForm EFFECT filed.via SEC EDGARVERIFIED Aug 10, 2026EVIDENCEVERIFIEDForm S-1 filed · S-1.via SEC EDGARVERIFIED Jul 30, 2026EVIDENCEVERIFIEDForm 8-K filed · 8-K.via SEC EDGARVERIFIED

Evidence · SEC filing timelineVERIFIED

Filed	Form	Document	Source
2026-08-14	10-Q	10-Q	SEC ↗
2026-08-13	424B4	424B4	SEC ↗
2026-08-12	EFFECT	CURIS INC	SEC ↗
2026-08-10	S-1	S-1	SEC ↗
2026-07-30	8-K	8-K	SEC ↗

VERIFIEDfrom a primary sourceDERIVEDcomputed by rulesINTERPRETEDreasoned from evidence

Assembled 0s ago · every panel labelled live or simulated · no fabricated metrics